Abstract
Testicular germ cell tumor (TGCT) is the most common cancer in young men and is notable for its high familial risks1,2. So far, six loci associated with TGCT have been reported3,4,5,6,7. From genome-wide association study (GWAS) analysis of 307,291 SNPs in 986 TGCT cases and 4,946 controls, we selected for follow-up 694 SNPs, which we genotyped in a further 1,064 TGCT cases and 10,082 controls from the UK. We identified SNPs at nine new loci (1q22, 1q24.1, 3p24.3, 4q24, 5q31.1, 8q13.3, 16q12.1, 17q22 and 21q22.3) showing association with TGCT (P < 5 × 10−8), which together account for an additional 4–6% of the familial risk of TGCT. The loci include genes plausibly related to TGCT development. PRDM14, at 8q13.3, is essential for early germ cell specification8, and DAZL, at 3p24.3, is required for the regulation of germ cell development9. Furthermore, PITX1, at 5q31.1, regulates TERT expression and is the third TGCT-associated locus implicated in telomerase regulation10.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Implementation of individualised polygenic risk score analysis: a test case of a family of four
BMC Medical Genomics Open Access 03 October 2022
-
Identification of 22 susceptibility loci associated with testicular germ cell tumors
Nature Communications Open Access 23 July 2021
-
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Signal Transduction and Targeted Therapy Open Access 17 December 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Bray, F., Ferlay, J., Devesa, S.S., McGlynn, K.A. & Moller, H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat. Clin. Pract. Urol. 3, 532–543 (2006).
Hemminki, K. & Li, X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br. J. Cancer 90, 1765–1770 (2004).
Rapley, E.A. et al. A genome-wide association study of testicular germ cell tumor. Nat. Genet. 41, 807–810 (2009).
Turnbull, C. et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat. Genet. 42, 604–607 (2010).
Turnbull, C. & Rahman, N. Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Int. J. Androl. 34, e86–e96 (2011).
Kanetsky, P.A. et al. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum. Mol. Genet. 20, 3109–3117 (2011).
Kanetsky, P.A. et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat. Genet. 41, 811–815 (2009).
Yamaji, M. et al. Critical function of Prdm14 for the establishment of the germ cell lineage in mice. Nat. Genet. 40, 1016–1022 (2008).
Schrans-Stassen, B.H., Saunders, P.T., Cooke, H.J. & de Rooij, D.G. Nature of the spermatogenic arrest in Dazl−/− mice. Biol. Reprod. 65, 771–776 (2001).
Qi, D.L. et al. Identification of PITX1 as a TERT suppressor gene located on human chromosome 5. Mol. Cell Biol. 31, 1624–1636 (2011).
Gilbert, D., Rapley, E. & Shipley, J. Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat. Rev. Cancer 11, 278–288 (2011).
Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353–361 (2013).
Eeles, R.A. et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotoyping array. Nat. Genet. 45, 385–391 (2013).
Schumacher, F.R. et al. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum. Mol. Genet. published online; 10.1093/hmg/ddt109 (5 March 2013).
Chung, C.C. et al. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat. Genet. published online; 10.1038/ng.2634 (12 May 2013).
Skakkebaek, N.E. Possible carcinoma-in-situ of the testis. Lancet 2, 516–517 (1972).
Kee, K., Angeles, V.T., Flores, M., Nguyen, H.N. & Reijo Pera, R.A. Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. Nature 462, 222–225 (2009).
Shan, Z. et al. A SPGY copy homologous to the mouse gene Dazla and the Drosophila gene boule is autosomal and expressed only in the human male gonad. Hum. Mol. Genet. 5, 2005–2011 (1996).
Yen, P.H., Chai, N.N. & Salido, E.C. The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. Hum. Mol. Genet. 5, 2013–2017 (1996).
Saxena, R. et al. The DAZ gene cluster on the human Y chromosome arose from an autosomal gene that was transposed, repeatedly amplified and pruned. Nat. Genet. 14, 292–299 (1996).
Reijo, R. et al. Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat. Genet. 10, 383–393 (1995).
Kurimoto, K., Yamaji, M., Seki, Y. & Saitou, M. Specification of the germ cell lineage in mice: a process orchestrated by the PR-domain proteins, Blimp1 and Prdm14. Cell Cycle 7, 3514–3518 (2008).
Ohinata, Y. et al. A signaling principle for the specification of the germ cell lineage in mice. Cell 137, 571–584 (2009).
Chia, N.Y. et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468, 316–320 (2010).
Tsuneyoshi, N. et al. PRDM14 suppresses expression of differentiation marker genes in human embryonic stem cells. Biochem. Biophys. Res. Commun. 367, 899–905 (2008).
Dettman, E.J. & Justice, M.J. The zinc finger SET domain gene Prdm14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32. PLoS ONE 3, e3823 (2008).
Dettman, E.J. et al. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors. Oncogene 30, 2859–2873 (2011).
Liu, B., Zhang, S., Hui, L., Qiu, X. & Cui, Z. Relationship between the expression of PRDM14 in non–small cell lung cancer and the clinicopathologic characteristics. Zhongguo Fei Ai Za Zhi 13, 867–872 (2010).
Nishikawa, N. et al. Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res. 67, 9649–9657 (2007).
Jin, J.L. et al. Catsper3 and Catsper4 encode two cation channel–like proteins exclusively expressed in the testis. Biol. Reprod. 73, 1235–1242 (2005).
Jin, J. et al. Catsper3 and Catsper4 are essential for sperm hyperactivated motility and male fertility in the mouse. Biol. Reprod. 77, 37–44 (2007).
Lobley, A., Pierron, V., Reynolds, L., Allen, L. & Michalovich, D. Identification of human and mouse CatSper3 and CatSper4 genes: characterisation of a common interaction domain and evidence for expression in testis. Reprod. Biol. Endocrinol. 1, 53 (2003).
Shete, S. et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41, 899–904 (2009).
Law, M.H. et al. Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk. J. Invest. Dermatol. 132, 485–487 (2012).
Stacey, S.N. et al. New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet. 41, 909–914 (2009).
Haiman, C.A. et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer. Nat. Genet. 43, 1210–1214 (2011).
Landi, M.T. et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet. 85, 679–691 (2009).
Petersen, G.M. et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet. 42, 224–228 (2010).
Rafnar, T. et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 41, 221–227 (2009).
Wang, P.J., McCarrey, J.R., Yang, F. & Page, D.C. An abundance of X-linked genes expressed in spermatogonia. Nat. Genet. 27, 422–426 (2001).
Wu, M.H. et al. Sequence and expression of testis-expressed gene 14 (Tex14): a gene encoding a protein kinase preferentially expressed during spermatogenesis. Gene Expr. Patterns 3, 231–236 (2003).
Greenbaum, M.P. et al. TEX14 is essential for intercellular bridges and fertility in male mice. Proc. Natl. Acad. Sci. USA 103, 4982–4987 (2006).
Mondal, G., Ohashi, A., Yang, L., Rowley, M. & Couch, F.J. Tex14, a Plk1-regulated protein, is required for kinetochore-microtubule attachment and regulation of the spindle assembly checkpoint. Mol. Cell 45, 680–695 (2012).
Obuse, C. et al. A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1. Nat. Cell Biol. 6, 1135–1141 (2004).
Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43–49 (2011).
Ward, L.D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930–D934 (2012).
Myers, S., Bottolo, L., Freeman, C., McVean, G. & Donnelly, P. A fine-scale map of recombination rates and hotspots across the human genome. Science 310, 321–324 (2005).
Acknowledgements
We thank the subjects with TGCT and the clinicians involved in their care for participation in this study. We also thank M. Warren Perry, D. Dudakia, J. Pugh, R. Linger, J. Marke, D. Hughes and D. Pernet for recruitment of subjects and database entry for the TGCT collections, and we thank the UK Genetics of Prostate Cancer Study (UKGPCS) study teams for the recruitment of the UKGPCS controls. This study would not have been possible without the contributions of the following: P. Hall (COGS); D.F. Easton (BCAC), A. Berchuck (OCAC), R. Eeles (PRACTICAL), G. Chenevix-Trench (CIMBA), J. Dennis, A.M. Dunning, A. Lee, E. Dicks and D.F. Easton (Cambridge); J. Benitez, A. Gonzalez-Neira and the staff of the CNIO genotyping unit; J. Simard and D.C. Tessier, F. Bacot, D. Vincent, S. LaBoissière and F. Robidoux and the staff of the McGill University and Génome Québec Innovation Centre; S.E. Bojesen, S.F. Nielsen, B.G. Nordestgaard and the staff of the Copenhagen DNA laboratory; and J.M. Cunningham, S.A. Windebank, C.A. Hilker, J. Meyer and the staff of Mayo Clinic Genotyping Core Facility. We acknowledge National Health Service funding to the National Institute for Health Research Biomedical Research Centre. The COGS (Collaborative Oncological Gene-environment Study) research initiative leading to these results has received support from the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175), Cancer Research UK (grants C1287/A10710 and C5047/A7357) and Prostate Action. This study makes use of data generated by the Wellcome Trust Case Control Consortium 2 (WTCCC2). A full list of the investigators who contributed to the generation of the data is available from the WTCCC website. D.F.E. is a Principal Research Fellow of Cancer Research UK. The initial GWAS study was supported by the Institute of Cancer Research, Cancer Research UK and the Wellcome Trust. This study was supported by the Institute of Cancer Research and Movember.
Author information
Authors and Affiliations
Consortia
Contributions
C.T. and N.R. designed the study. C.T., N.R., R.A.H. and UKTCC coordinated the studies that provided case samples. D.F.E., J.P., R.E., Z.K.-J. and K.M. coordinated studies that provided control samples. C.T., H.M., S.S. and A.E. coordinated sample management, selection and transfer. M.R.S., D.F.E., D.T.B., J.N. and E. Rapley designed and executed the original case genome-wide genotyping. C.T. designed the statistical analyses. C.T. and E. Ruark conducted statistical analyses with assistance from K.L. and F.Z. C.T. drafted the manuscript with assistance from N.R., E. Ruark, J.S., J.N., D.T.B. and E.P. All authors contributed to the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Additional information
Details appear in the Supplementary Note.
Supplementary information
Supplementary Text and Figures
Supplementary Note, Supplementary Tables 1–5, Supplementary Figure 1 (PDF 109 kb)
Supplementary Table 6
Regulatory annotation of variants within nine new TGCT loci (Excel file) (XLSX 33 kb)
Supplementary Table 7
Expression of genes within 500kb of nine new TGCT SNPs (Excel file) (XLSX 16 kb)
Rights and permissions
About this article
Cite this article
Ruark, E., Seal, S., McDonald, H. et al. Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45, 686–689 (2013). https://doi.org/10.1038/ng.2635
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2635
This article is cited by
-
Implementation of individualised polygenic risk score analysis: a test case of a family of four
BMC Medical Genomics (2022)
-
Predicted leukocyte telomere length and risk of germ cell tumours
British Journal of Cancer (2022)
-
Identification of 22 susceptibility loci associated with testicular germ cell tumors
Nature Communications (2021)
-
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Signal Transduction and Targeted Therapy (2019)
-
Testicular germ cell tumor: a comprehensive review
Cellular and Molecular Life Sciences (2019)